Product
ZIMBERELIMAB
1 clinical trial
4 indications
Indication
Pancreatic CancerIndication
Pancreatic AdenocarcinomaIndication
Squamous Cell Carcinoma of PancreasIndication
Adenosquamous Carcinoma of the PancreasClinical trial
Phase Ib/II Open-Label, Multicenter, Randomized Study Evaluating the Safety and Efficacy of 'Switch Maintenance' Combination Immunotherapy Using AB154, AB122, and APX005M in Patients With Metastatic Pancreatic CancerStatus: Recruiting, Estimated PCD: 2026-01-31